Thuy X. Le

Publications

143

Citations

H-Index

1997

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Thuy X. Le is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacotherapy, and drug discovery.

Top concepts

MedicineChemistryBiochemistryPharmacologyDrug DiscoveryDrug ResistancePharmacotherapyDrug DevelopmentNatural SciencesOrganic Chemistry

Publications per year

1997–2010

Publications

Rational design of novel, potent piperazinone and imidazolidinone BACE1 inhibitors

Jared N. Cumming, Thuy X. Le, Sethu Geetha Babu et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 58 citations · Full text

Medicinal Chemistry, Biochemistry, Drug Design +11

Piperazine sulfonamide BACE1 inhibitors: Design, synthesis, and in vivo characterization

Jared N. Cumming, Suresh Babu, Ying Huang et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 46 citations · Full text

Medicinal Chemistry, Vivo Characterization, Biochemistry +12

2,5-Diketopiperazines, new chiral auxiliaries for asymmetric Diels-Alder reactions

Thuy X. Le, Jacqueline C. Bussolari, William V. Murray · Tetrahedron Letters · 1997 · 22 citations

Organic Chemistry, New Chiral Auxiliaries, Stereoselective Synthesis +3

Glycosylmanganese pentacarbonyl complexes: an organomanganese-based approach to the synthesis of C-glycosyl derivatives

Philip DeShong, Eric D. Soli, Greg A. Slough et al. · Journal of Organometallic Chemistry · 2000 · 17 citations

Engineering, C-glycosyl Derivatives, Organic Chemistry +7

Rows per page

1–4 of 4